206 related articles for article (PubMed ID: 15480903)
1. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
[TBL] [Abstract][Full Text] [Related]
2. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
[TBL] [Abstract][Full Text] [Related]
3. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
[TBL] [Abstract][Full Text] [Related]
4. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
Iseki K; Kinjo K; Iseki C; Takishita S
Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
[TBL] [Abstract][Full Text] [Related]
5. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
Iseki K; Iseki C; Ikemiya Y; Kinjo K; Takishita S
Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
[TBL] [Abstract][Full Text] [Related]
6. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
7. Predictors of end-stage renal disease and body mass index in a screened cohort.
Iseki K; Ikemiya Y; Fukiyama K
Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure and risk of end-stage renal disease in a screened cohort.
Iseki K; Ikemiya Y; Fukiyama K
Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
[TBL] [Abstract][Full Text] [Related]
9. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003).
Iseki K; Kohagura K; Sakima A; Iseki C; Kinjo K; Ikemiya Y; Takishita S
Hypertens Res; 2007 Jan; 30(1):55-62. PubMed ID: 17460372
[TBL] [Abstract][Full Text] [Related]
10. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and the risk of development of end-stage renal disease in a screened cohort.
Iseki K; Ikemiya Y; Kinjo K; Inoue T; Iseki C; Takishita S
Kidney Int; 2004 May; 65(5):1870-6. PubMed ID: 15086929
[TBL] [Abstract][Full Text] [Related]
12. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
[TBL] [Abstract][Full Text] [Related]
13. Renal outcomes in chronic kidney disease.
Iseki K
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
[TBL] [Abstract][Full Text] [Related]
15. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH; Schmid CH; Stark PC; Toto R; Remuzzi G; Ruggenenti P; Marcantoni C; Becker G; Shahinfar S; De Jong PE; De Zeeuw D; Kamper AL; Strangaard S; Levey AS
Nephrol Dial Transplant; 2003 Oct; 18(10):2047-53. PubMed ID: 13679479
[TBL] [Abstract][Full Text] [Related]
16. The current state of chronic dialysis treatment in Japan (as of December 31, 2000).
Ther Apher Dial; 2003 Feb; 7(1):3-35. PubMed ID: 12921111
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing the development of end-stage renal disease.
Iseki K
Clin Exp Nephrol; 2005 Mar; 9(1):5-14. PubMed ID: 15830267
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria and the risk of developing end-stage renal disease.
Iseki K; Ikemiya Y; Iseki C; Takishita S
Kidney Int; 2003 Apr; 63(4):1468-74. PubMed ID: 12631363
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of diabetes mellitus in a rural Greek population.
Melidonis AM; Tournis SM; Kompoti MK; Lentzas IL; Roussou VR; Iraklianou SL; Michail IM; Mariolis AM
Rural Remote Health; 2006; 6(1):534. PubMed ID: 16579675
[TBL] [Abstract][Full Text] [Related]
20. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.
Jee SH; Boulware LE; Guallar E; Suh I; Appel LJ; Miller ER
Arch Intern Med; 2005 Oct; 165(19):2299-304. PubMed ID: 16246998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
